Page last updated: 2024-08-23

paclitaxel and Paronychia

paclitaxel has been researched along with Paronychia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belum, VR; Blinder, VS; Goldfarb, SB; Gucalp, A; Kamboj, M; Lacouture, ME; Virgen, CA	1
Hua, YM; Huang, KL; Huang, TW; Lin, KY; Loh, EW; Su, HC; Tam, KW	1
Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D	1
Albares, MP; Belinchón, I; Betlloch, I; Blanes, M; Pascual, JC; Vergara, G	1
Gordon, RJ; Osterwalder, B; Planting, AS; Pronk, LC; Reigner, B; Sparreboom, A; Twelves, C; Vasey, P; Verweij, J	1

Reviews

1 review(s) available for paclitaxel and Paronychia

Article	Year
Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis. European journal of cancer care, 2019, Volume: 28, Issue:5 Topics: Cryotherapy; Docetaxel; Humans; Nail Diseases; Neoplasms; Oils, Volatile; Onycholysis; Paclitaxel; Paronychia; Pigmentation Disorders; Plant Oils; Taxoids; Waxes	2019

Trials

1 trial(s) available for paclitaxel and Paronychia

Article	Year
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours. British journal of cancer, 2000, Volume: 83, Issue:1 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Biotransformation; Capecitabine; Carboxylic Ester Hydrolases; Deamination; Deoxycytidine; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Fever; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Paronychia; Prodrugs; Remission Induction; Taxoids; Treatment Outcome	2000

Article

Year

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.

British journal of cancer, 2000, Volume: 83, Issue:1

Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Biotransformation; Capecitabine; Carboxylic Ester Hydrolases; Deamination; Deoxycytidine; Dexamethasone; Docetaxel; Drug Administration Schedule; Female; Fever; Fluorouracil; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Methylprednisolone; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Paronychia; Prodrugs; Remission Induction; Taxoids; Treatment Outcome

2000

Other Studies

3 other study(ies) available for paclitaxel and Paronychia

Article	Year
The microbial flora of taxane therapy-associated nail disease in cancer patients. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Bacteria; Breast Neoplasms; Dermatomycoses; Docetaxel; Female; Fungi; Humans; Paclitaxel; Paronychia; Skin Diseases, Bacterial; Taxoids	2018
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy]. Investigacion clinica, 2014, Volume: 55, Issue:1 Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections	2014
Subungal abcesses secondary to paclitaxel. Dermatology online journal, 2003, Volume: 9, Issue:3 Topics: Abscess; Acute Disease; Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Paclitaxel; Paronychia	2003